[Microbiological diagnosis of deep seated mycoses].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Carrada Bravo.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Cholera toxin (CT) and the analogous heat-labile enterotoxin (LT) from Escherichia coli have several immunomodulating effects that might explain their adjuvant action in stimulating secretory mucosal IgA after oral immunization. In mice experimental model, these effects include: enhanced antigen presentation by macrophages and other cell types; promotion of isotype differentiation in B cells leading to increased IgA formation; and other important effects on T cell proliferation and lymphokine production. The adjuvant activity is linked to the ADP-ribosylating action of CT with increased cyclic AMP formation in the affected cell, and thus it may be difficult to eliminate the enterotoxic activity without loss of adjuvanticity. However, both CT and its non-toxic B subunit moiety (CTB) have been shown to enhance the mucosal immune response to various epitopes or antigens covalently linked to these molecules. This now give promise that those antigens could become a useful vehicle to facilitate the induction of specific secretory IgA response to a broad range of antigens for human vaccination against cholera and other enteric infections.
Review of leishmaniasis immunopathogenesis, the models in the laboratory animals, and the last advances in the experimental vaccine administration. In recent years, there have been important progresses that have contributed substantially to classify the role of the interleukins and other chemical mediators in the immunologic response. All these advances open the door to the production of better and more immunogenic vaccines, that in a near future will be employed advantageous in the human beings.